Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nerdy A | NRDY | Nov 26, 2024 | 1.47 | +5.76 |
Net Lease Office Properties When Issued | NLOP | Nov 26, 2024 | 31.34 | -0.73 |
Net Power A | NPWR | Nov 26, 2024 | 12.45 | -6.32 |
NetApp | NTAP | Nov 26, 2024 | 129.60 | +2.71 |
Netcapital | NCPL | Nov 26, 2024 | 1.95 | -5.34 |
NetEase ADR | NTES | Nov 26, 2024 | 86.21 | +0.95 |
Netflix | NFLX | Nov 26, 2024 | 872.60 | +0.81 |
NETGEAR | NTGR | Nov 26, 2024 | 25.07 | +3.13 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 26, 2024 | 44.74 | -0.94 |
NetScout Systems | NTCT | Nov 26, 2024 | 22.11 | +0.77 |
NETSOL Technologies | NTWK | Nov 26, 2024 | 2.66 | -0.37 |
Netstreit | NTST | Nov 26, 2024 | 16.22 | -0.49 |
Network-1 Technologies | NTIP | Nov 26, 2024 | 1.33 | -0.75 |
Neuberger Berman | NML | Nov 26, 2024 | 9.24 | -0.32 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 26, 2024 | 7.74 | -0.51 |
Neuberger Berman Municipal Fund | NBH | Nov 26, 2024 | 10.73 | -0.19 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 26, 2024 | 13.16 | +0.23 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 26, 2024 | 3.84 | -0.52 |
NeueHealth | NEUE | Nov 26, 2024 | 4.90 | +0.82 |
Neumora Therapeutics | NMRA | Nov 26, 2024 | 9.77 | +1.03 |
Neuraxis | NRXS | Nov 26, 2024 | 3.06 | +0.83 |
Neurobo Pharmaceuticals | NRBO | Nov 26, 2024 | 2.35 | -2.89 |
Neurocrine Biosciences | NBIX | Nov 26, 2024 | 127.91 | +0.63 |
Neurogene | NGNE | Nov 26, 2024 | 26.87 | +20.41 |
NeuroMetrix | NURO | Nov 26, 2024 | 4.25 | +0.64 |
Neuronetics | STIM | Nov 26, 2024 | 0.95 | -1.66 |
NeuroOne | NMTC | Nov 26, 2024 | 0.70 | +13.74 |
Neuropace | NPCE | Nov 26, 2024 | 10.20 | -4.32 |
NeuroSense Therapeutics | NRSN | Nov 26, 2024 | 0.90 | +2.57 |
Nevro | NVRO | Nov 26, 2024 | 4.32 | -5.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.